The effect of consuming meat enriched in walnut paste on platelet aggregation and thrombogenesis varies in volunteers with different apolipoprotein A4 genotype

Nutricion Hospitalaria

Volumn 25, Issue 5, 2010, Pages 746-754

  Canales, A ^a,b   Benedi, J ^b   Bastida, S ^a,b   Corella, D ^c   Guillen, M ^c   Librelotto, J ^a,b   Nus, M ^a,b   Sanchez Muniz F J ^a,b  

^a Departamento de Nutrición y Bromatología I Nutrición   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

APOA4 polymorphism; Functional food; Low fat meat; Meat enriched in walnut paste; Platelet aggregation; Prostacyclin; Thrombogenic ratio; Thromboxane

Indexed keywords

JUGLANS;

6 OXOPROSTAGLANDIN F1 ALPHA; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV; APOLIPOPROTEIN A4; DNA; PROSTACYCLIN; THROMBOXANE A2; THROMBOXANE B2;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; MALE; MEAT; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOSIS; WALNUT;

6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; APOLIPOPROTEINS A; BLOOD PRESSURE; CROSS-OVER STUDIES; DIET; DNA; ENERGY INTAKE; EPOPROSTENOL; FEMALE; GENOTYPE; HUMANS; JUGLANS; MALE; MEAT; MIDDLE AGED; PLATELET AGGREGATION; POLYMORPHISM, GENETIC; THROMBOSIS; THROMBOXANE A2; THROMBOXANE B2;

EID: 78049256896     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.5.4504     Document Type: Article

References (45)

1. Niemiec P, Zak I, Wita K. Modification of the coronary artery disease risk associated with the presence of traditional risk factors by insertion/deletion polymorphism of the ACE gene. Genet Test 2007; 11: 353-359.
2. Ordovas JM. Genetic interactions with diet influence the risk of cardiovascular disease. Am J Clin Nutr 2006; 83: 443S- 446S.
3. Kwon JS, Snook JT, Wardlaw GM, Hwang DH. Effects of diets high in saturated fatty acids, canola oil, or safflower oil on platelet function, thromboxane B2 formation, and fatty acid composition of platelet phospholipids. Am J Clin Nutr 1991; 54: 351-358.
4. Sanchez-Muniz FJ, Oubina P, Rodenas S, Benedi J, Cuesta C. Platelet aggregation, thromboxane production and thrombogenic ratio in postmenopausal women consuming high oleic acid-sunflower oil or palmolein. Eur J Nutr 2003; 42: 299-306.
5. Hornstra G. Dietary lipids, platelet function and arterial thrombosis. Wien Klin Wochenschr 1989; 101: 272-277. (Pubitemid 19098696)
6. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008; 197: 12-24.
7. Chan JK, McDonald BE, Gerrard JM, Bruce VM, Weaver BJ, Holub BJ. Effect of dietary alpha-linolenic acid and its ratio tolinoleic acid on platelet and plasma fatty acids and thrombogenesis. Lipids 1993; 28: 811-817.
8. Oubiña P, Sánchez-Muniz FJ, Rodenas S, Cuesta C. Eicosanoid production, thrombogenic ratio, and serum and LDL peroxides in normo- and hypercholesterolaemic postmenopausal women consuming two oleic acid-rich diets with different content of minor components. Br J Nutr 2001; 85: 41-47.
9. Canales A, Bastida S, Librelottto J, Nus M, Sanchez-Muniz FJ, Benedi J. Platelet aggregation, eicosanoid production and thrombogenic ratio in individuals at high cardiovascular risk consuming meat enriched in walnut paste. A crossover, placebo-controlled study. Br J Nutr 2009; 102: 134-141.
10. Feldman EB. The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J Nutr 2002; 132: 1062S-1101S.
11. Ros E, Nuñez I, Perez-Heras A, Serra M, Gilabert R, Casals E, Deulofeu R. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 2004; 109: 1609-1614.
12. Salas-Salvado J, Fernandez-Ballart J, Ros E, Martinez-Gonzalez MA, Fito M, Estruch R, Corella D, Fiol M, Gomez-Gracia E, Aros F, Flores G, Lapetra J, Lamuela-Raventos R, Ruiz- Gutierrez V, Bullo M, Basora J, Covas MI. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med 2008; 168: 2449-2458.
13. Canales A, Benedí J, Nus M, Librelotto J, Sanchez-Montero JM, Sánchez-Muniz FJ. Effect of walnut-enriched restructured meat in the antioxidant status of overweight/obese senior subjects with at least one extra CHD-risk factor. J Am Coll Nutr 2007; 26: 225-232.
14. Nus M, Frances F, Librelotto J, Canales A, Corella D, Sanchez- Montero JM, Sanchez-Muniz FJ. Arylesterase activity and antioxidant status depend on PON1-Q192R and PON1- L55M polymorphisms in subjects with increased risk of cardiovascular disease consuming walnut-enriched meat. J Nutr 2007; 137: 1783-1788.
15. Olmedilla-Alonso B, Granado-Lorencio F, Herrero-Barbudo C, Blanco-Navarro I, Blazquez-Garcia S, Perez-Sacristan B. Consumption of restructured meat products with added walnuts has a cholesterol-lowering effect in subjects at high cardiovascular risk: a randomised, crossover, placebo-controlled study. J Am Coll Nutr 2008; 27: 342-348.
16. Kalogeris TJ, Rodriguez MD, Tso P. Control of synthesis and secretion of intestinal apolipoprotein A-IV by lipid. J Nutr 1997; 127: 537S-543S.
17. Weinberg RB, Cook VR, DeLozier JA, Shelness GS. Dynamic interfacial properties of human apolipoproteins A-IV and B-17 at the air/water and oil/water interface. J Lipid Res 2000; 41: 1419-1427.
18. Weinberg RB, Geissinger BW, Kasala K, Hockey K J, Terry JG, Easter L, Crouse JR. Effect of apolipoprotein A-IV genotype and dietary fat on cholesterol absorption in humans. J Lipid Res 2000; 41: 2035-2041.
19. Go M, Schonfeld G, Pfleger B, Cole TG, Sussman NL, Alpers DH. Regulation of intestinal and hepatic apoprotein synthesis after chronic fat and cholesterol feeding. J Clin Invest 1988; 81: 1615-1620.
20. Weinberg RB., Jordan M, Steinmetz A. Distinctive structure and function of human apolipoprotein variant, apoA-IV-2. J Bio Chem 1990; 265: 18372-18378.
21. Hubacek JA, Bohuslavova R, Skodova Z, Pitha J, Bobkova D, Poledne R. Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change. Clin Chem Lab Med 2007; 45: 316-320.
22. Herron KL, Lofgren IE, Adiconis X, Ordovas JM, Fernandez ML. Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake. Atherosclerosis 2006; 184: 113-120.
23. Keys A, Anderson JT, Grande F Serum cholesterol response to changes in die IV. Particular saturated fatty acids in the diet. Metabolism 1965; 14: 776-787.
24. Paulus JM, Aster RH. Production distribution, life-span and fate of platelets. In Hematology, 1985, 3rd ed.; 1185 [WJ Williams, E. Beutler, AJ Erslev and MA Lichtman, editors]. New York: McGraw Hill.
25. Serrano A, Cofrades S, Ruiz-Capillas C, Olmedilla-Alonso B, Herrero-Barbudo C, Jiménez-Colmenero F. Nutritional profile of restructured beef steak with added walnuts. Meat Sci 2005; 70: 647-654.
26. Moreiras O, Carbajal A, Cabrera L, Cuadrado C (editors). Tablas de composición de Alimentos. Madrid: Editorial Pirámide. 2007
27. Olmedilla Alonso B, Granado Lorencio F, Herrero Barbudo C, Blanco Navarro I, Sánchez-Muniz FJ. Productos cárnicos funcionales preparados con nuez. Evaluación del efecto funcional. Alimentación 2005; 24: 37-41.
28. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3: 135-158.
29. Hishinuma T, Yu GS, Takabatake M, Nakagawa Y, Ito K, Nishikawa M, Ishibashi M, Suzuki K, Matsumoto M, Toyoda T, Mizugaki M. Analysis of the thromboxane/prostacyclin balance in human urine by gas chromatography/selected ion monitoring: abnormalities in diabetics. Prostaglandins Leukot Essent Fatty Acids 1996; 54: 445-449. (Pubitemid 26313464)
30. Hixson J, Powers PK. Restriction isotyping of human apolipoprotein A-IV: rapid typing of known isoforms and detection of a new isoform that deletes a conserved repeat. J Lipid Res 1991; 32: 1529-1535.
31. Mensink RP, van Houwelingen AC, Kromhout D"Hornstra G. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr 1999; 69: 213-219.
32. Nus M, Ruperto M, Sanchez-Muniz FJ. Nuts, cardio and cerebrovascular risks. A Spanish perspective. Arch Latinoam Nutr 2004; 54: 137-148.
33. Mata P, Ordovas JM, Lopez-Miranda J, Lichtenstein AH, Clevidence B, Judd JT"Schaefer E J. ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arterioscler Thromb 1994; 14: 884-891.
34. Aviram M, Fuhrman B, Keidar S, Maor I, Rosenblat M, Dankner, Brook G. Platelet-modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation. J Clin Chem Clin Biochem 1989; 27, 3-12.
35. Kramer HJ, Stevens J, Grimminger F, Seeger W. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. Biochem Pharmacol 1996; 52: 1211-1217.
36. Das UN. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 2008; 7: 37.
37. Kinsella JE, Lokesh B, Stone RA. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr 1990; 52: 1-28.
38. Das UN. COX-2 inhibitors and metabolism of essential fatty acids. Med Sci Monit 2005; 11: RA233-RA237.
39. Szczeklik A, Gryglewski RJ, Domagala B, Dworski R, Basista M. Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemost 1985; 54: 425-430.
40. Murray M, Pizzorno J. Procyanidolic oligomeriers. In The Textbook of Natural medicine 1999; 2nd ed.: 899-902 [M Murray and J Pizzorno, editors]. London: Churchill Livington.
41. Lee JH and Hwang DH. Dietary fatty acids and eicosanoids. In Fatty acids in foods and their health implications. 2008; 713-739 [CK Chow, editor]. Boca Raton: CRC Press Taylor"Francis Group.
42. Fine AM. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Alternative Med Rev 2000; 5: 144-151.
43. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 1997; 95: 179-189.
44. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998; 56: 317-333.
45. Oliver SR, Wright VP, Parinandi N, Clanton TL. Thermal tolerance of contractile function in oxidative skeletal muscle: no protection by antioxidants and reduced tolerance with eicosanoid enzyme inhibition. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1695-R1705.